Clinical trials: Burn Wounds - Partial Thickness (2nd Degree), open to volunteers
Partial-thickness Burn, Pain
Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.
This study plans to look at the benefits of banana leaves as a primary burn wound dressing. Study patients will be compared to historical patients
- Conditions
- Partial-thickness Burn, Pain, Second Degree Burn
- Trial name
- NCT07453732
- Testing
- Banana leaf dressing
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of Colorado, Denver
Burns Degree Third, Burn (Disorder)
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
To evaluate the safety and efficacy of realSKIN® to provide complete wound closure of mixed-depth, full-thickness burn wounds as an alternative treatment to autografting.
- Conditions
- Burns Degree Third, Burn (Disorder), Burn Degree Second, Thermal Burn
- Trial name
- NCT06223269
- Testing
- Skin Xenotransplant, Autograft(ing)
- Where
- 4 sites in United States
- Volunteers
- 50 people
- Sponsor
- XenoTherapeutics, Inc.
Burn Wounds - Partial Thickness (2nd Degree)
Field Shield Wound Dressing Study
This study is to compare the Field Shield Wound Dressing (FSWD) as a treatment for burn wounds to a standard of care burn wound dressing to evaluate healing, infection, pain/discomfort, and deepening of wound over time.
- Trial name
- NCT07337616
- Testing
- Field Shield Wound Dressing, Silverlon
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- KeriCure Medical
Burn, Burn Wounds - Partial Thickness (2nd Degree)
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep…
- Trial name
- NCT07025408
- Testing
- KJ101, Chymotrypsin
- Where
- China
- Volunteers
- 144 people
- Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.